Novavax Secures Major Pfizer Vaccine Licensing Deal as Investor Pressure Mounts and Shares Jump on $500 Million Milestone Potentia

USA Herald – Novavax has landed a major pharmaceutical partnership after signing a new vaccine technology licensing agreement with Pfizer, a move that sent the biotech company’s shares sharply higher and signaled renewed commercial interest in its immune-boosting platform. Under the agreement, Pfizer will gain non-exclusive access to Novavax’s Matrix-M adjuvant, a proprietary technology designed

USA Herald – Novavax has landed a major pharmaceutical partnership after signing a new vaccine technology licensing agreement with Pfizer, a move that sent the biotech company’s shares sharply higher and signaled renewed commercial interest in its im… [1374 chars]

Source: USA Herald | Published: 2026-01-21T09:07:08Z

Credit: USA Herald